CIRB Studies

Below is the current list of studies covered by the CIRB. Participants should refer to ClinicalTrials.gov for general information about clinical trials. Institutions should refer to the Clinical Trials Support Unit (CTSU) website  for enrollment requirements and accrual status information. 

Study documents approved after July 1, 2013 are available to participating institutions for covered studies on the CTSU website. To request documents approved before July 1, 2013, participating institutions can contact the CIRB Helpdesk.

Review CIRB
Study Number Network Study Title CIRB
UAZ20-01-02 CP-CTNet_CLO-University of Arizona An extended follow-up study of the HPV vaccine delayed booster trial Cancer Prevention and Control CIRB
UAZ2015-05-01 CP-CTNet_CLO-University of Arizona A prospective, single-arm, open-label, non-randomized, phase IIA trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys Cancer Prevention and Control CIRB
UAZ2015-05-02 CP-CTNet_CLO-University of Arizona M4OC-Prevent: Metformin for Oral Cancer Prevention Cancer Prevention and Control CIRB
UAZ2016-08-02 CP-CTNet_CLO-University of Arizona A feasibility trial of alternating intravaginal application of 5-fluorouracil and imiquimod for treatment of high-grade cervical squamous intraepithelial lesions Cancer Prevention and Control CIRB
UAZ2017-09-02 CP-CTNet_CLO-University of Arizona Clinical Study of Avmacol® for Detoxification of Tobacco Carcinogens in Heavy Smokers Cancer Prevention and Control CIRB
UAZ21-06-01 CP-CTNet_CLO-University of Arizona Phase II Randomized, Double Blind, Placebo-Controlled Trial of the Broccoli Seed and Sprout Extract (BSSE), Avmacol ES, to Evaluate Sustained Detoxification of Tobacco Carcinogens in Heavy Smokers Cancer Prevention and Control CIRB
UAZ21-07-01 CP-CTNet_CLO-University of Arizona M4OC-Prevent 2.0: Phase IIb Trial of Metformin for Oral Cancer Prevention Cancer Prevention and Control CIRB
UMI21-05-01 CP-CTNet_LAO-University of Michigan Obeticholic Acid for Prevention in Barrett’s Esophagus Cancer Prevention and Control CIRB
UMI22-09-01 CP-CTNet_LAO-University of Michigan Phase IIA Trial of Acolbifene (20 mg) vs Low Dose Tamoxifen (5 mg) in Pre-menopausal Women at High Risk for Development of Breast Cancer Cancer Prevention and Control CIRB
UMI23-13-01 CP-CTNet_LAO-University of Michigan An Early Phase 1 Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy Cancer Prevention and Control CIRB